Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03763331 · ClinicalTrials.gov registry record · NA
Home-based Leg Heat Therapy
A NA study, sponsored by Indiana University.
- Completed
- Registry status
- NA
- Development phase
- 34
- Enrollment target
NCT03763331: Completed NA study, sponsored by Indiana University.
NCT03763331 is a NA study that has completed, run by Indiana University. The registered enrollment target is 34 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03763331, a NA study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- NA
- Development phase
- 34 participants
- Enrollment target
Study Summary
The objective of this study is to evaluate the benefits of participating for 8 weeks in a home-based daily treatment with heat therapy (HT) or a thermoneutral control intervention, as assessed by vascular function, walking tolerance and quality of life.
Primary Outcome
Change in 6-min walk distance from baseline to the 8-week follow-up
Interventions
- DEVICE Heat Therapy
- DEVICE Control/Sham Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2019-01-14 |
| Est. Completion | 2021-06-21 |
| Phase | NA |
What the finished NCT03763331 record still lists
NCT03763331 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 34 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Heat Therapy is the first listed.
NCT03763331 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03763331 about?
NCT03763331 is a clinical study titled "Home-based Leg Heat Therapy". The objective of this study is to evaluate the benefits of participating for 8 weeks in a home-based daily treatment with heat therapy (HT) or a thermoneutral control intervention, as assessed by vascular function, walking tolerance and quality of life.
What is the current status of trial NCT03763331?
This trial is currently completed. It is a NA study. The enrollment target is 34 participants. The study started on 2019-01-14. Estimated completion is 2021-06-21.
What interventions are being tested in trial NCT03763331?
The interventions under investigation include: Heat Therapy (DEVICE), Control/Sham Treatment (DEVICE).
Who is sponsoring clinical trial NCT03763331?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03763331's enrollment target sits among peer trials
34 1570th of 2000 higher than 427 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02897063 · 34 participants · Phase 1
Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
- NCT03906617 · 34 participants · Phase 4
Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine
- NCT03992378 · 34 participants · NA
Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis
- NCT04047849 · 34 participants · Phase 4
Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI